Stock listing
Nattaro Labs Ab
Selected listing: NATTA · NGM · SEK · SE
Nattaro Labs Ab (NGM:NATTA), Health Technology. Latest release May 6, 2026: NATTA: Revenue up 15% and first-ever positive EBITDA, driven by growth and cost…
- Ticker
- NGM:NATTA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NGM
- Currency
- SEK
About Nattaro Labs Ab
The company focuses on innovative solutions in its industry. Investors can find detailed information about Nattaro Labs Ab's performance and offerings on its public company page.
Latest news from Nattaro Labs Ab
NATTA: Revenue up 15% and first-ever positive EBITDA, driven by growth and cost control
May 6, 2026
NATTA: Revenue up 10% but losses deepened; international growth and new capital support future outlook
February 25, 2026
NATTA: Q3 2025 sales up 34% year-over-year, but margins and cash flow pressured by inventory write-downs
November 19, 2025
NATTA: Q2 2025 saw a 37% revenue drop, strong gross margin, and ongoing need for new capital
August 27, 2025
NATTA: Strong international sales growth and new partnerships drive expansion, but losses persist
May 7, 2025